4.5 Review

Dining With Inflammatory Bowel Disease: A Review of the Literature on Diet in the Pathogenesis and Management of IBD

期刊

INFLAMMATORY BOWEL DISEASES
卷 26, 期 2, 页码 181-191

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/ibd/izz268

关键词

diet; inflammatory bowel disease; Crohn's disease; ulcerative colitis

向作者/读者索取更多资源

Inflammatory bowel diseases (IBDs) are chronic immune-related diseases hypothesized to be a sequela of an interplay of genetic predisposition and environmental exposures. The global incidence of IBD is increasing, and more patients are exploring diet as a means to explain and treat their IBD. In fact, many patients strongly believe diet plays a fundamental role in the onset and management of their IBD. However, a significant proportion of patients report limited nutritional education from their provider, and providers report limited nutritional resources to aid in discussions with patients. This imbalance between supply and demand likely reflects the previous paucity of available literature characterizing the influence of diet in IBD. To address this gap in knowledge, we review the available literature to characterize the role of diet in the pathogenesis, exacerbation, and treatment of IBD. We aim to provide patients and providers with resources to better understand and discuss the role of diet in IBD, with the overall goal of improving patient care and satisfaction.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Gastroenterology & Hepatology

Patient Perception and Clinical Impact of Direct-to-Consumer Advertising in Inflammatory Bowel Disease

Phillip Gu, Edward Yang, Punya Chittajallu, Cathy McNeill, Amit G. Singal, John H. Kwon, Tasneem F. Ahmed

Summary: The study found that the majority of IBD patients had a favorable perception of IBD-DTCA, believing that the advertisements helped them become aware of new treatments and potential risks. However, IBD-DTCA rarely led to patient-provider discussions or changes in treatment regimens.

DIGESTIVE DISEASES AND SCIENCES (2021)

Meeting Abstract Gastroenterology & Hepatology

VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY

Phillip Gu, Avneesh Chhabra, Punya Chhittajallu, Christopher Chang, Denisse Mendez, Andrew Gilman, David Fudman, Yin Xi, Linda Feagins

INFLAMMATORY BOWEL DISEASES (2021)

Meeting Abstract Gastroenterology & Hepatology

VISCERAL ADIPOSE TISSUE INFLUENCES ANTI-TUMOR NECROSIS FACTOR (TNF) TREATMENT RESPONSE IN IBD

Phillip Gu, Avneesh Chhabra, Punya Chhittajallu, Christopher Chang, Denisse Mendez, Andrew Gilman, David Fudman, Yin Xi, Linda Feagins

INFLAMMATORY BOWEL DISEASES (2021)

Article Gastroenterology & Hepatology

Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy

Phillip Gu, Avneesh Chhabra, Punya Chittajallu, Christopher Chang, Denisse Mendez, Andrew Gilman, David Fudman, Yin Xi, Linda A. Feagins

Summary: The study found that visceral adipose tissue volume is associated with anti-TNF treatment response in a non-dose dependent manner, while patients with high visceral fat index have a significantly increased risk of surgery after starting anti-TNF treatment.

INFLAMMATORY BOWEL DISEASES (2022)

Article Gastroenterology & Hepatology

Diet in the Pathogenesis and Management of Crohn's Disease

Phillip Gu, Linda A. Feagins

GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2022)

Article Gastroenterology & Hepatology

Effect of Obesity on Risk of Hospitalization, Surgery, and Serious Infection in Biologic-Treated Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort Study

Phillip Gu, Jiyu Luo, Jihoon Kim, Paulina Paul, Berkeley Limketkai, Jenny S. Sauk, Sunhee Park, Nimisha Parekh, Kai Zheng, Vivek Rudrapatna, Gaurav Syal, Christina Ha, Dermot P. McGovern, Gil Y. Melmed, Phillip Fleshner, Samuel Eisenstein, Sonia Ramamoorthy, Parambir S. Dulai, Brigid S. Boland, Eduardo Grunvald, Uma Mahadevan, Lucila Ohno-Machado, William J. Sandborn, Siddharth Singh

Summary: Obesity is not associated with increased risk of hospitalization, surgery, or serious infections in biologic-treated patients with inflammatory bowel diseases.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2022)

Review Gastroenterology & Hepatology

Medical and Surgical Implications of Mesenteric Adipose Tissue in Crohn's Disease: A Review of the Literature

Phillip Gu, Shishir Dube, Dermot P. B. McGovern

Summary: Alterations in mesenteric adipose tissue play a significant role in Crohn's disease, but their clinical significance is still unclear. Current studies have limitations, but they suggest that mesenteric adipose tissue may serve as a marker for disease severity, surgical risk, and postoperative outcomes. Additionally, it could be a potential target for mitigating postoperative recurrence of Crohn's disease.

INFLAMMATORY BOWEL DISEASES (2023)

Meeting Abstract Gastroenterology & Hepatology

POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Angela Mujukian, Dalin Li, Philip Debbas, Andrea Banty, Edward J. Feldman, Christina Ha, Susie Lee, Shervin Rabizadeh, Theodore Stein, Theodore Solomon, Gaurav Syal, Stephan R. Targan, Eric A. Vasiliauskas, David Ziring, Nirupama Bonthala, Melissa Hampton, Valeriya Pozdnyakova, Phillip Gu, Joseph Ebinger, Sandy Joung, Jane C. Figueiredo, Akil Merchant, Noah Merin, Karen L. Reckamp, Keren Appel, Rashmi Kumar, Brigid Boland, Aline Charabaty, Michael V. Chiorean, Erica Cohen, Ann D. Flynn, John F. Valentine, Adam C. Ehrlich, David Fudman, Sarah C. Glover, Arash A. Horizon, Dmitry Karayev, Benjamin Kretzmann, Jason K. Hou, Caroline Hwang, Mark Lazarev, Donald Lum, Rebecca Fausel, Swapna Reddy, Ryan McConnell, Mark Mattar, Mark Metwally, Arthur Ostrov, Parekh Nimisha, Laura H. Raffals, David T. Rubin, Sarah Sheibani, Corey A. Siegel, Douglas C. Wolf, Ziad H. Younes, Susan Cheng, Jonathan G. Braun, Dermot P. B. Mcgovern, Gil Melmed

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

CLINICAL, RADIOGRAPHIC, SEROLOGIC, AND GENETIC ASSOCIATIONS WITH HEPATIC STEATOSIS SEVERITY AND NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)

Phillip Gu, Shishir Dube, Norman Gellada, Dalin Li, Talin Haritunians, Eric A. Vasiliauskas, Christina Ha, Gaurav Syal, Nirupama Bonthala, Shaohong Yang, Phillip Fleshner, Gil Melmed, Mazen Noureddin, Cindy Kallman, Stephan R. Targan, Dermot P. B. Mcgovern

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

OBESITY IS NOT ASSOCIATED WITH INCREASED RISK OF ADVERSE TREATMENT OUTCOMES OR SERIOUS INFECTION IN INFLAMMATORY BOWEL DISEASES PATIENTS (IBD) STARTING NEW BIOLOGIC THERAPY

Phillip Gu, Jiyu Luo, Paulina Paul, Berkeley N. Limketkai, Jenny S. Sauk, Sunhee Park, Nimisha K. Parekh, Kai Zheng, Vivek A. Rudrapatna, Gaurav Syal, Christina Ha, Dermot P. B. Mcgovern, Gil Melmed, Phillip Fleshner, Samuel Eisenstein, Sonia Ramamoorthy, Parambir Dulai, Brigid Boland, Uma Mahadevan, Lucila Ohno-Machado, William J. Sandborn, Siddharth Singh

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION

Dalin Li, Alexander Xu, Joseph Ebinger, Philip Debbas, Andrea Banty, Edward J. Feldman, Christina Ha, Susie Lee, Shervin Rabizadeh, Theodore Stein, Theodore Solomon, Gaurav Syal, Stephan R. Targan, Eric A. Vasiliauskas, David Ziring, Nirupama Bonthala, Melissa Hampton, Angela Mujukian, Valeriya Pozdnyakova, Phillip Gu, Sandy Joung, Keren Appel, Rashmi Kumar, Brigid S. Boland, Aline Charabaty, Michael V. Chiorean, Erica Cohen, Oriana M. Damas, Ann D. Flynn, John F. Valentine, Adam C. Ehrlich, David Fudman, Sarah C. Glover, Arash A. Horizon, Dmitry Karayev, Benjamin Kretzmann, Jason K. Hou, Caroline Hwang, Mark Lazarev, Donald Lum, Rebecca Fausel, Swapna Reddy, Ryan McConnell, Mark Mattar, Mark Metwally, Arthur Ostrov, Nimisha K. Parekh, Laura H. Raffals, David T. Rubin, Sarah Sheibani, Corey A. Siegel, Douglas C. Wolf, Ziad H. Younes, Ian M. Kaplan, John Prostko, Kimia Sobhani, Akil Merchant, Susan Cheng, Jonathan G. Braun, Dermot P. B. Mcgovern, Gil Melmed

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

NOVEL ASSOCIATIONS OF SARCOPENIA WITH CLINICAL, RADIOGRAPHIC, BLOOD PARAMETER, AND POLYGENIC RISK SCORE (PRS) MEASURES IN CROHN'S DISEASE (CD)

Shishir Dube, Norman Gellada, Dalin Li, Talin Haritunians, Phillip Gu, Shaohong Yang, Gregory J. Botwin, Stephan R. Targan, Damini Dey, Yaniv Raphael, Cindy Kallman, Dermot P. B. Mcgovern

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

NOVEL ASSOCIATIONS OF BONE DENSITY WITH CLINICAL, BLOOD PARAMETERS, SEROLOGIC, AND POLYGENIC RISK SCORE (PRS) VARIABLES IN INFLAMMATORY BOWEL DISEASE (IBD)

Shishir Dube, Dalin Li, Norman Gellada, Talin Haritunians, Phillip Gu, Shaohong Yang, Gregory J. Botwin, Stephan R. Targan, Damini Dey, Yaniv Raphael, Cindy Kallman, Dermot P. B. Mcgovern

GASTROENTEROLOGY (2022)

Meeting Abstract Gastroenterology & Hepatology

Dyssynergic Defecation Evaluation in Veterans With Chronic Constipation: Preliminary Results of a Veterans Affairs (VA) Experience

Jane Lim, Maryann Osayande, Phillip Gu, Kerry Dunbar

AMERICAN JOURNAL OF GASTROENTEROLOGY (2021)

Meeting Abstract Gastroenterology & Hepatology

VISCERAL FAT INDEX INFORMS RISK OF MEDICALLY REFRACTORY IBD AND NEED FOR SURGERY IN PATIENTS STARTING ANTI-TUMOR NECROSIS (TNF) THERAPY

Phillip Gu, Avneesh Chhabra, Punya Chittajallu, Christopher Chang, Denisse Mendez, Andrew J. Gilman, David Fudman, Yin Xi, Linda A. Feagins

GASTROENTEROLOGY (2021)

暂无数据